Bristol-Myers Squibb

Member of UN Global Compact

Headquarters in USA

Bristol-Myers Squibb website

🔎 Run a search for “Bristol-Myers Squibb”

Get RSS feed of these results

All stories

Article
1 January 2000

The business response to HIV/AIDS: impact and lessons learned

Author: Prince of Wales International Business Leaders Forum in collaboration with UNAIDS and Global Business Council on HIV/AIDS

[Section 5, "Profiles of business activities in response to HIV/AIDS", includes profiles of American International Assurance, Thailand; The Body Shop, Japan; Warsaw Marriott Hotel; Larsen & Toubro, India; Volkswagen do Brasil; Molson Breweries,...

Read more

Article
28 February 2001

Merck, Bristol-Myers Squibb Announce Major Price Reductions for Poorest Countries: Major Access Progress but Questions Remain

Author: John S. James, AIDS Treatment News

...Merck...announced it would sell Crixivan...in some poor countries for $600 per patient per year...Merck claims that it will not make a profit...Bristol-Myers Squibb Company announced that it was making its drugs ddI and d4T available "in every...

Read more

Article
15 March 2001

Cheaper drugs for Africa: Manufacturer [Bristol-Myers Squibb] to relax its patent on two Aids remedies

Author: Andrew Clark and Julian Borger, Guardian [UK]

Read more

Article
16 May 2001

Fighting Back in Botswana: Nearly 36 percent of adults in Botswana are believed to have HIV, the virus that causes AIDS.

Author: NewsHour with Jim Lehrer, PBS

Elizabeth Farnsworth reports on how Botswana's government is trying to tackle the crisis, in part three of a four-part series. "Diamonds from mines like this are crucial to Botswana's economy, and as more and more workers ended up sick, Debswana ...

Read more

Article
25 October 2001

A battered Bayer opts out of a fight over its Cipro patent

Author: Ed Silverman, Star-Ledger [New Jersey]

Rather than suffer a bruising battle for its Cipro patent and risk more damage to its image, the German drug giant will sell the anthrax-fighting antibiotic to the [U.S.] federal government at a drastically reduced price -- 95 cents a tablet, about...

Read more

Article
4 January 2002

Walden Asset Management Announces Shareholder Advocacy Actions for 2002

Author: Walden Asset Management

[includes shareholder resolutions on the following issues & companies: Climate Change - Exxon Mobil, ChevronTexaco and Occidental Petroleum; Mercury Pollution - J.C. Penney and HCA; Indigenous Peoples' Rights - Lehman Brothers; Sweatshop/Vendor...

Read more

Article
31 January 2002

Public-Private Partnership Leads Fight Against HIV/Aids [in Botswana]

Author: allAfrica.com

...The Gates Foundation, partnerships with Merck, Bristol-Myers Squibb and the Harvard AIDS Institute all form "very strong" U.S. components of the southern African nation's Aids fight.

Read more

Article
19 March 2002

Report Diagnoses Ills in the Pharmaceutical Sector

Author: Willliam Baue, SocialFunds.com

A German rating agency reports that many pharmaceutical companies are failing to follow the example of the sector’s leaders in solving environmental and social problems...The report analyzed the 22 largest pharmaceutical companies in the world, based...

Read more

Article
1 April 2002

Broadening the Corporate Commitment to HIV and AIDS

Author: Business for Social Responsibility

[refers to positive steps by Coca-Cola, Hewlett-Packard, Unilever, Anglo American, BHP Billiton, Bristol-Myers Squibb, Merck, DaimerChrysler, De Beers]

Read more

Article
8 April 2002

Firms pushed to disclose their impact on society

Author: Irwin Arieff, Reuters

A coalition of governments, businesses and public interest groups launched last week a global campaign to encourage companies to issue public reports on their impact on society and the environment [Global Reporting Initiative]...The GRI guidelines are...

Read more